The Treatment Of BPH Through 1470nm Semi-Conductor Laser Mediated Transurethral Prostate Vaporization

Objective To investigate the treatment of 1470 nm semi-conductor transurethral vaporization of the prostate for benign prostatic hyperplasia(BPH) evaluated the efficacy of laser.Methods 72 cases of BPH patients were collected, and randomly divided into two groups with 36 cases in each group. One group applied the 1470 nm laser mediated transurethral vaporization of the prostate, named laser group. The other group underwent transurethral resection surgery, which named TURP group. The operation time, intra-operative blood loss and the postoperative catheterization were compared between the two groups. The international prostate symptom score(IPSS), quality of life score(QOL), post-void residual(PVR) and maximum urine flow rate(Qmax) were recorded in three different time points of the two group patients, the time before surgery and three months after operation followed-up.Results The operations were successful in all the patients. The postoperative cathe terization time in the laser group was 3.18 ± 1.04 d and the operation time was 63.73 ± 6.56 min. While in the transurethral group, the catheterization time was 4.05 ± 1.08 d, the operation time was 72.88 ± 12.56 min. The IPSS, QOL, PVR an d Qmax were significant improved in the two groups. No re-catheterization or reoperation was occurred in the two groups.Conclusion Compared with traditional treatment, 1470 nm laser transurethral vapori zation of the prostate can be more effective and safer therapy for the BPH. It has less blood loss in the intra-operative and post-operation, less catheterization time, less complications. It is worth to be further applied in the clinical.